Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00214019 · ClinicalTrials.gov registry record · NA
The Effect of Salmeterol on Eosinophil (EOS) Function
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT00214019 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 36 participants.
The verdict
NCT00214019, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
This study is designed to test the hypothesis that salmeterol use, and not fluticasone use or the combination treatment with fluticasone and salmeterol, is associated with a greater number of sputum eosinophils following antigen challenge and, under these circumstances, the migrating peripheral blood eosinophils are less adherent.
Interventions
- DRUG Placebo
- DRUG Fluticasone
- DRUG salmeterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2003-11 |
| Est. Completion | 2008-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00214019
The ClinicalTrials.gov registry entry for NCT00214019 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00214019 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00214019 about?
NCT00214019 is a clinical study titled "The Effect of Salmeterol on Eosinophil (EOS) Function". This study is designed to test the hypothesis that salmeterol use, and not fluticasone use or the combination treatment with fluticasone and salmeterol, is associated with a greater number of sputum eosinophils following antigen challenge and, under these circumstances, the migrating peripheral bloo...
What is the current status of trial NCT00214019?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2003-11. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00214019?
The interventions under investigation include: Placebo (DRUG), Fluticasone (DRUG), salmeterol (DRUG).
Who is sponsoring clinical trial NCT00214019?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.